ArticleBlood cancer journal2011

The therapeutic human CD38 antibody daratumumab improves the anti-myeloma effect of newly emerging multi-drug therapies.

M S van der Veer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.